Faecal microbiota transplantation in patients with haematological malignancies undergoing cellular therapies: from translational research to routine clinical practice
Authors:
- 26 September 2022
- journal article
- review article
- Published by Elsevier in The Lancet Haematology
- Vol. 9 (10) , e776-e785
Abstract
No abstract availableKeywords
Funding Information
- Janssen Pharmaceutica
- Roche
- University of Adelaide
- Sanofi
- Amgen
- Pfizer
- Celgene
This publication has 79 references indexed in Scilit:
- The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantationBlood, 2014
- Fecal Microbiota Transplant for Treatment of Clostridium difficile Infection in Immunocompromised PatientsAmerican Journal of Gastroenterology, 2014
- Diet rapidly and reproducibly alters the human gut microbiomeNature, 2013
- European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in LeukemiaHaematologica, 2013
- The Intestinal Microbiota Modulates the Anticancer Immune Effects of CyclophosphamideScience, 2013
- The Human Gut Microbiome and Its DysfunctionsDigestive Diseases, 2013
- Duodenal Infusion of Donor Feces for RecurrentClostridium difficileNew England Journal of Medicine, 2013
- Structure, function and diversity of the healthy human microbiomeNature, 2012
- Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model systemJournal of Antimicrobial Chemotherapy, 2010
- A human gut microbial gene catalogue established by metagenomic sequencingNature, 2010